In this POV, Morgan Hartzell, VP, Client Services, explores several key strategies to ensure marketing remains genuine and trustworthy, while still leveraging the benefits of AI technology ..read more

At EVERSANA INTOUCH, we embrace GROW TALENT daily. Last week, our learning & development team, account, and PMO leaders hosted the grand finale of the Business Excellence Program in Chicago. This training enhances communication, presentation, strategic thinking, and business management skills. This year, 39 team members nationwide completed the program, elevating their skills ..read more

This POV explores how decentralized healthcare models and data ownership are transforming patient loyalty, and highlights strategies to foster loyalty in this new landscape. Download the POV to learn more ..read more

Learn the key takeaways and insights from a recent Med Ad News article about how to make a difference in rare disease marketing with creativity, data and innovation ..read more

Learn how pharmaceutical companies can address gaps in women's health related to rare disease, and improve outcomes for patients ..read more

During February, EVERSANA® and EVERSANA INTOUCH honored and celebrated Black History Month with a series of impactful events and initiatives. This year’s theme was “Continuing the Dream: Honoring the Past, Shaping the Present and Empowering the Future,” which aimed to shed light on the past, present and future of Black individuals ..read more

EVERSANA INTOUCH's Head of Art and Creative Excellence shares three key elements that bring creative excellence into pharma marketing ..read more

Rare and ultra-rare diseases face problems most brands do … turned up to 11. Budgets? Smaller. Patient pool? Even smaller. Healthcare providers (HCPs) who understand the condition? Sometimes even smaller than that. Treatment options can be limited, access can be hard to find and diagnosis time can sometimes be measured in decades rather than months ..read more

In our third annual report on the state of brand planning, EVERSANA surveyed nearly 100 brand planning executives across biopharmaceuticals, diagnostics and medical devices. This year, we expanded our assessment by hosting 111 marketing leaders from around the globe at a client advisory board in Napa Valley, California, to hear firsthand about key advancements and persistent challenges in brand planning. Download the POV to learn more ..read more

During the Super Bowl, is when we see some of the most entertaining and memorable commercials. However, pharmaceutical companies often remain on the sidelines during this prime advertising opportunity. In a recent article in MM+M, pharma industry thought leaders, including John Kenny, Chief Strategy Officer, and Susan Perlbachs, Chief Creative Officer, offer their insights as to why pharma brands are hesitant to invest in Super Bowl ads despite the massive audience ..read more